Merck
MRK
#40
Rank
โ‚น33.199 T
Marketcap
โ‚น13,467
Share price
-0.25%
Change (1 day)
63.53%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): โ‚น92.63

According to Merck's latest financial reports the company's current EPS (TTM) is โ‚น92.81. In 2025 the company made an earnings per share (EPS) of โ‚น683.22 an increase over its 2024 EPS that were of โ‚น631.71.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น92.63-86.44%
2025โ‚น683.228.15%
2024โ‚น631.714308.46%
2023โ‚น14.33-97.32%
2022โ‚น535.5310.92%
2021โ‚น482.8084.68%
2020โ‚น261.43-27.2%
2019โ‚น359.1063.44%
2018โ‚น219.71151.11%
2017โ‚น87.49-54.58%
2016โ‚น192.6130.21%
2015โ‚น147.93-61.99%
2014โ‚น389.14180.51%
2013โ‚น138.72-31.82%
2012โ‚น203.466.62%
2011โ‚น190.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น624.30 572.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น490.66 428.68%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น66.36-28.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น252.70 172.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,887 3,010.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,624 1,650.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น185.10 99.44%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น422.44 355.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น268.92 189.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น42.06-54.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel